title: Interchangeability between control material and patient serum in tumor biomarker assessment.
authors.forename: R
authors.initials: R
authors.lastname: Dittadi
authors.forename: M
authors.initials: M
authors.lastname: Gion
mesh_terms: D014408:Biomarkers, Tumor; D018394:CA-125 Antigen / Q000097:blood; D018395:CA-19-9 Antigen / Q000097:blood; D002138:Calibration; D002272:Carcinoembryonic Antigen / Q000097:blood; D005293:Ferritins / Q000378:metabolism; D006801:Humans; D018396:Mucin-1 / Q000097:blood; D017430:Prostate-Specific Antigen / Q000097:blood; D012015:Reference Standards; D013997:Time Factors
chemical_list: D014408:Biomarkers, Tumor; D018394:CA-125 Antigen; D018395:CA-19-9 Antigen; D002272:Carcinoembryonic Antigen; D018396:Mucin-1; D005293:Ferritins; D017430:Prostate-Specific Antigen